General form of registration statement for all companies including face-amount certificate companies

STOCKHOLDERS??? EQUITY (DEFICIT) (Tables)

v3.21.2
STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
 6 Months Ended 12 Months Ended
May 31, 2021
Nov. 30, 2020
Equity [Abstract]    
Schedule of assumptions used for warrants  

The assumptions that the Company used to determine the grant-date fair value of warrants granted for the years ended November 30, 2020 and 2019 were as follows:

      2020   2019
  Risk free rate     0.35 – 1.57%       1.69 – 3.05%  
  Expected dividends     0 %     0 %
  Expected volatility     98.28 – 109.93%       150 – 159%  
  Expected life     3.54 – 3.77 years       4.35 – 5 years  
  Market price of the Company's common stock on date of grant   $ 0.25       $0.14 – 0.16  
  Exercise price   $ 0.25     $ 0.25  

 
Schedule of warrants activity

The following table summarizes warrant activity, which includes the incentive warrants, during the six months ended May 31, 2021:

 

          Weighted-Average  
          Exercise  
    Number of     Price  
    Warrants     $  
Outstanding at November 30, 2020     585,739       2.40  
Granted     —       —  
Exercised     (486,684 )     2.50  
Outstanding at May 31, 2021     99,055       1.91  
Exercisable at May 31, 2021     99,055       1.91  

The following table summarizes warrant activity, which includes the incentive warrants, for the year ended November 30, 2020:

 

      Number of
Warrants		     Weighted-Average
Exercise
Price
$		  
               
Outstanding, November 30, 2018       26,041,160       0.19  
Granted       22,223,058       0.25  
Expired       (2,476,999 )     (0.16 )
Outstanding, November 30, 2019       45,787,219       0.22  
Granted       2,146,836       0.25  
Exercised       (42,076,668 )     (0.21 )
Outstanding, November 30, 2020       5,857,386       0.24  
                   
Exercisable, November 30, 2020       5,857,386       0.24  
Exercisable. November 30, 2019       45,037,219       0.22
Schedule weighted-average remaining contract  

The warrants outstanding at the end of the year had weighted-average remaining contract lives as follows:

 

    2020     2019  
      (years)       (years)  
Total outstanding warrants     2.82       3.55  
Total exercisable warrants     2.82       3.50